Company page

Uniqure N.v.

Uniqure N.V. is a public company traded under the ticker QURE in the American market, with a market capitalization of approximately $2.89 billion. The company focuses on developing gene therapies for genetic diseases. Uniqure aims to provide innovative treatment solutions that address unmet medical needs.